Table 5.
Univariate and multivariate linear regression analyses in association with Ucarr.
| Univariate linear regression | Multivariate linear regression | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | ||||||||
| β | t-value | p value | β | t-value | p value | β | t-value | p value | |
| Age | −1.84 | 2.10 | 0.039 | −1.98 | 2.25 | 0.027 | −1.98 | 2.23 | 0.028 |
| Gender | −5.29 | 0.29 | 0.772 | −16.55 | 0.95 | 0.347 | −8.81 | 0.51 | 0.611 |
| BMI | 6.50 | 2.61 | 0.010 | 5.09 | 2.07 | 0.041 | 4.92 | 1.95 | 0.053 |
| HT | 15.72 | 0.87 | 0.388 | 15.75 | 0.88 | 0.382 | 21.18 | 1.18 | 0.241 |
| EF | 0.26 | 0.20 | 0.835 | ||||||
| LAD | 1.37 | 0.94 | 0.349 | ||||||
| eGFR | 0.62 | 0.95 | 0.342 | ||||||
| T-chol | 0.22 | 0.84 | 0.403 | ||||||
| HbA1c | 16.56 | 1.23 | 0.221 | ||||||
| Glu | 0.94 | 2.86 | 0.005 | 0.80 | 2.37 | 0.020 | |||
| Tau | 1.10 | 2.64 | 0.009 | 0.82 | 1.95 | 0.054 | |||
Abbreviations are as in Table 3. BMI, EF, LAD, eGFR, and T-chol were subjected to analysis at 1 kg/m2, 1%, 1 mm, 1 mL/min/1.73 m2, and 1 mg/dL increase, respectively. Age and Glu/Tau were per 10-year and 10-nmol/mL increase, respectively. In the regression analyses, male = 1 and female = 2; absence of hypertension = 1 and presence = 2. Model 1 includes all clinical and laboratory variables in addition to Glu, but not Tau. Model 2 includes all variables in addition to Tau, but not Glu.